Ahmad, K. and K. Jahan. Studies on the Preventative and Curative
Action of Ascorbic Acid on the Neurological Toxicity of Monosodium Glutamate. Institute
of Nutritional and Food Science - University of Dhaka.
Aizenman, E., Frosch, M.P., and Lipton, S.A. 1988. Responses Mediated by
Excitatory Amino Acid Receptors in Solitary Retinal Ganglion Cells from Rat. J.
Physiol 395: 75-91.
Arbogast, Lydia A. and James L. Voogt. 1990. Sex-Related Alterations in
Hypothalamic Tyrosine Hydroxylase After Neonatal Monosodium Glutamate Treatment. Neuroendocrinology
52 (5): 460-7.
Arndt, T. et al. 1993. Reduced, Positive Nitrogen Balance and Elevated
Plasma Free Fatty Acid Concentration in Growing, Glutamate-induced Obese Rats. Journal
of Experimental Animal Science 36(1):12-8.
Aschner, M er al. 1990. Interactions of Methylmercury with Rat
Primary Astrocyte Cultures: Inhibition of Rubidium and Glutamate Uptake and Induction of
Swelling. Brain Research 530 (2): 245-50.
Aust, L. et al. 1993. Postprandial Thermogenesis of Rats With
Glutamate Induced Obesity in Relation to Energy Intake. Zeitschrift fur
Ernahrungswissenschaft 32(1):71-3.
Banister, E. W. et al. 1978. Effect of High-Pressure Oxygen on Cellular
Fine Structure, Ammonia and Glutamate Metabolism. Underwater
Physiology: 215-232.
Barbour, B. et al. 1991. Electrogenic Uptake in Glutamate and Aspartate into
Glial Cells Isolated from the Salamander (Ambystoma) Retina. J Physiol 436:
169-183.
Bennett, Gary J. 1998. The Role of Glutamate in Chronic Inflammatory Pain and
Painful Peripheral Neuropathies. Speaker, NIH National Meeting. The Glutamate
Cascade: Common Pathways of Central Nervous System Disease States. May3-5, 1998.
Betraan, M.A. et al. 1992. Nitrogen Metabolism in Obesity Induced by
Monosodium-L-Glutamate in Rats. International Journal of Obesity and Related
Metabolic Disorders 16(8):555-64.
Botey, J. et al. 1988. Monosodium Glutamate and Skin Pathology in
Pediatric Allergology. Allergology and Immunopathology 16 (6)
425-428.
Broadwell, R.D. and Sofroniew. 1993. Serum Proteins Bypass the
Blood-Brain Fluid Barriers For Extracellular Entry to the Central Nervous System.
Experimental Neurology 120:245-263.
Bruno, V. et al. 1994. Protective Action of Idebenone Again Excitotoxic
Degeneration in Cultured Cortical Neurons. Neurosci Lett 178: 193-196.
Cammer, W et al. 1990. Reactive Gliosis in the Brains of Lewis Rats with
Experimental Allergic Encephalomyelitis. Journal of Neuroimmunology 27
(2-3): 111-120.
Canfield, P.R. et al. 1992. Aspartame Exacerbates EEG Spike-wave Discharge in
Children with Generalized Absence Epilepsy: A Double-blind Controlled Study. Neurology
42: 1000-1003.
Cangro, Charles Benjamin. 1986. Immunocytochemical and Biochemical
Investigation into the Distribution and Metabolism of Glutamate and
N-acetylaspartylglutamate Along the Spinal Sensory Axis. Ph.D. dissertation,
Georgetown University. Dissertation Abstracts Online. 47(2B): 4781.
Chan, P.H. et al. 1990. Attenuation of Glutamate-Induced Neuronal
Swelling and Toxicity in Transgenic Mice Overexpressing Human CuZn-Superoxide Dismutase.
Acta Neurochir Suppl 51: 245-7.
Cheung, W. T. et al. 1988. Neonatal Monosodium -L-Glutamate Treatment
Reduced Lipolytic Response of Rat Epididymal Adipose Tissue. General
Pharmacology 19 (4): 507-512.
Cho, Y. and S. Bannai. 1990. Uptake of Glutamate and Cysteine in C-6
Glioma Cells and in Cultured Astrocytes. Journal of Neurochemistry 55
(6): 2091-7.
Choi, D.W. 1988. Glutamate Neurotoxicity and Diseases of the Nervous System.
Neuron 1: 623-634.
Choi, D.W. 1994. Glutamate Receptors and the Induction of Excitotoxic
Neuronal Death. Prog. Brain. Res. 100: 47-51.
Choi, D. W. 1990. The Role of Glutamate Neurotoxicity in
Hypoxic-Ischemic Neuronal Death. Annual Review of Neuroscience
13:171-182.
Choi, Dennis W. 1998. Manipulating Glutamatergic Neurotransmission for
Therapeutic Gains: The Example of Brain Ischemia. Speaker, NIH National Meeting.
The Glutamate Cascade: Common Pathways of Central Nervous System Disease States.
May3-5, 1998.
Conner-Kerr, Teresa Ann. 1992. A Possible Mechanism of Excitotoxicity:
Autoregulation of Glutamate Release from Hippocampal Mossy Fiber Terminals. Ph.D.
dissertation, East Carolina University. Dissertation Abstracts Online. 53(11B): 5571.
Coyle, J.T. and P. Puttfarcken. 1993. Oxidative Stress, Glutamate, and
Neurodegenerative Disorders. Science 262: 689-695.
Danbolt, N.C. 2001. Glutamate Uptake. Progressive
Neurobiology 65(1):1-105.
Dawson, R., Jr. and Z. Annau. 1983. A Behavioral Assessment of Arcuate
Nucleus Damage After a Single Injection of Monosodium Glutamate. Neurobehavioral
Toxicology and Teratology 5 (4): 399-406.
Dawson, R., Jr. et al. 1989. Age and Dose Dependent Effects of Neonatal
Monosodium Glutamate (MSG) Administration To Female Rats. Neurotoxicol.
Teratol. 11 (4) 331-337.
Dawson, R., Jr. et al. 1989. A Pharmacological Anaysis of Food Intake
Regulation in Rats Treated Neonatally with Monosodium L-Glutamate (MSG). Pharmacol.
Biochem. Behav. 32 (2): 391-398.
Dawson, R., Jr. et al. 1997. Attenuation of Leptin-Mediated Effects by
Monosodium Glutamate (MSG)-Induced Arcuate Nucleus Damage. American
Journal of Physiology.
De Erausquin, G. A. et al. 1990. Gangliosides Normalize Distorted
Single-Cell Intracellular Free CA Super (2+) Dynamics After Toxic Doses of Glutamate in
Cerebellar Granule Cells. Proceedings of the National Academy of Sciences,
USA 87 (20): 8017-8021.
De Groot, A. P. et al. 1988. Induction of Hyperplasia in the Bladder
Epithelium of Rats by a Dietary Excess of Acid or Base: Implications for
Toxicity/Carcinogenicity Testing. Food and Chemical Toxicology 26 (5):
425-434.
De Schutter, Erik, 1997. A New Functional Role for Cerebellar Long Term
Depression. Progress in Brain Research 114:529-542.
Dolnikoff, M. S. et al. 1988. Neonatal Treatment with Monosodium
Glutamate Increases Plasma Corticosterone in Rat. Neuroendocrinology
48 (6): 645-649.
Dolnikoff, M. S. et al. 2001. Decreased Lipolysis and Enhanced
Glycerol and Glucose Utilization by Adipose Tissue Prior to Development of Obesity in
Monosodium Glutamate (MSG) treated Rats. Int. Journal of
Obesity-Related Metabolic Disorders.
During, M.J. and Spencer, D.D. 1993. Extracellular Hippocampal
Glutamate and Spontaneous Seizure in the Conscious Human Brain. Lancet
341:1607-0610.
Dzogas, Zoran. 1996. In Vivo Activity of Canine Expiratory
Bulbospinal Neurons is Differentially Affected by two Non-N-Methyl-D-Aspartate Receptor
Antagonists. Croatian Medical Journal 37(1).
Eck, H. P. et al. 1990. Partial Recovery of Lymphocyte Activity in
Patients with Colorectal Carcinoma After Curative Surgical Treatment and Return of Plasma
Glutamate Concentrations to Normal Levels. Journal of Cancer Research and
Clinical Oncology 116(6): 648-50.
Erdo, S. L. and M. Schaefer. 1991. Memantine is Highly Potent in
Protecting Cortical Cultures Against Excitotoxic Cell Death Evoked by Glutamate and N
Methyl-D-Aspartate. Eur. Journal of Pharmacology 198 (2-3):
215-218.
Favaron, M. et al. 1990. Down-regulation of Protein Kinase C Protects
Cerebellar Granule Neurons in Primary Culture from Glutamate-Induced Neuronal Death.
Proceedings of the National Academy of Sciences of the United States of America
87 (5): 1983-1987.
Fernandez-Aguado, C. et al. 1989. Liver Glutamate and Glutamine
Concentration in Experimental Hepatocarcinogenesis: Effect of Glutathione. Biochem.
Chem. Carcinog., (Proc. Satell. Symp. 14th Int. Congr. Biochem. ) pp 203-9
Fernstrom, J.D. 2000. Pituitary Hormone Secretion in Normal Male
Humans: Acute Responses to a Large, Oral Dose of Monosodium Glutamate. Journal
of Nutrition 130 (Suppl 4s):1053-7.
Fisher, R. S. 1991. Glutamate and Epilepsy. Frontiers of
Clinical Neuroscience 11: 131-146.
Frandsen, A. et al. 1990. Novel Glutamate Antagonists Selectively
Protect Against Kainic Acid Neurotoxicity in Cultured Cerebral Cortex Neurons.
Journal of Neurochemistry 55 (5): 1821-1823.
Frandsen, A. and Arne Schousboe. 1991. Dantrolene Prevents Glutamate
Cytotoxicity and Calcium Release From Intracellular Stores in Cultured Cerebral Corical
Neurons. Journal of Neurochemistry 56 (3): 1075-8.
Frankel, Arthur et al. 1990. Role of Arginine 180 and Glutamic Acid 177
of Ricin Toxin A Chain in Enzymic Inactivation of Ribosomes. Molecular Cell
Biology 10 (12) 6257-63.
Freese, A. et al. 1990. Characterization and Mechanism of Glutamate
Neurotoxicity in Primary Striatal Cultures. Brain Research 521 (1-2):
254-264.
Fundytus, M.E., 2001. Glutamate Receptors and Nociception: Implications for
the Drug Treatment of Pain. CNS Drugs 2001 Jan: 15(1): 29-58.
Furkawa, K. et al. 1997. The Actin-severing Protein Gelsolin Modulates
Calcium Channel and NMDA Receptor Activities and Vulnerability to Excitotoxicity in
Hippocampal Neurons. J. Neurosci 17: 8178-8186.
Gao, J. et al. 1994. Transplacental Neurotoxic Effects of
Monosodium Glutamate on Structures and Functions of Specific Brain Areas of Filial Mice.
Sheng Li Hsueh Pao Acta Physiologica Sinica 46(1):44-51.
Gray, A.M., Rawls, S.M. Shippenberg, T.S., and McGinty, J.F. 1999. Kappa
Opioid Agonist, U-69593, Decreases Acute Amphetamine-evoked Bahaviors andCalcium-dependent
Dialysate Levels of Dopamine and Glutamate in the Ventral Striatum. J Neurochem 73:
1066-1074.
Greene, James G. 1998. Bioenergeetics and Excitotoxicity: An Examination of
Neurotoxicity Secondary to Succinate Dehydrogenase Inhibition. Ph.D. dissertation. The
University of Rochester. Dissertation Abstracts Online. 59(03B): 0933.
Greenmayre, J. and Porter, R. 1994. Anatomy and Physiology of glutamate in
the CNS. Neurol 44: s7-sl3.
Greenmayre, J. Timothy. 1998. Glutamatergic Mechanisms in the Cause and
Treatment of Parkinson’s Disease. Speaker, NIH National Meeting. The Glutamate
Cascade: Common Pathways of Central Nervous System Disease States. May3-5, 1998.
Hahn, J. S. et al. 1988. Central Mammalian Neurons Normally Resistant to
Glutamate Toxicity Are Made Sensitive by Extracellular Ca Super (2+): Toxicity is blocked
by the N-Methyl-D-Aspartate Antagonist. Proceedings of the National
Academy of Sciences USA 85 (17) 6556-6560.
Halpain, S., Hipolito, A. and Saffer, L. 1998. Regulation of F-actin
Stability in Dendritic Spines by Glutamate Receptors and Calcineurin. J Neurosci 18:
9835-9844.
Helton, D.R. et al. 1998. Anxiolytic and Side-Effect Profile of
LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic
Glutamate Receptors. Journal of Pharmacology and Experimental Therapeutics
284(2):651-60.
Himi, T. et al. 1990. Spider Toxin (JSTX-3) Inhibits the Convulsions
Induced by Glutamate Agonists. J. Neural Transm. 80 (2): 95-104.
Hussain, M.M. et al. 1989. Characterization of Glutamate Dehydrogenase
Isoproteins Purified From the Cerebellum of Normal Subjects and Patients with Degenerative
Neurological Disorders, and From Human Neoplastic Cell Lines. Journal of
Biol. Chemistry 264 (34): 20730-735.
Ishikawa, K et al. 1997. Hippocampal Degeneration Inducing Impairment of
Learning in Rats: Model of Dementia? Behavioural Brain Research
83(1-2):39-44.
Janssen, Raelyn et al. 1991. Glutamate Neurotoxicity in the Developing
Rat Cochlea: Physiological and Morphological Approaches. Brain
Research 552 (2): 255-64.
Jensen, Frances E. 1998. Role of Glutamate Receptor Maturation in Perinatal
Brain Injury. Speaker, NIH National Meeting. The Glutamate Cascade:
Common Pathways of Central Nervous System Disease States. May3-5, 1998.
Kato, S. et al. 1990. Gliotoxic Effects of Alpha- Aminodipic Acid
Isomers on the Carp Retina: A Long Term Observation. Neuroscience 36
(1): 145-153.
Kayastha, Arvind M. et al. 1991. Site-Directed Mutagenesis of the Beta
Subunit of Tryptophan Synthase From Salmonella Typhimurium. Role of Active Site
Glutamic Acid. J. Biol. Chem. 266 (12): 7618-25.
Kirchgessner, A. L. et al. 1997. Excitotoxicity in the enteric
nervous system. Journal of Neuroscience 17:8807-8816.
Kiskin, N. I. et al. 1989. Blocking Action of Nephalia Clavata Spider
Toxin on Ionic Currents Activated by Glutamate and its Agonists in Isolated Hippocampal
Neurons. Neurophysiology 21 (2): 110-116.
Klunk, W. E. et al. 1991. L Phosphoserine A Metabolite Elevated in
Alzheimer's Disease Interacts with Specific L Glutamate Receptor Subtypes. Journal
of Neurochem 56 (6): 1997-2003.
Koh, B.K., et al. 1996. Effects of Cysteine on Free Radical Production and
Protein Modification in Extruded Wheat Flour. Cereal Chem 73(1): 115-122.
Koh, Jaeyoung. 1989. Glutamate Receptor-Mediated Neurotoxicity in Murine
Neuronal Cultures. Ph.D. dissertation, Stanford University. Dissertation Abstracts
Online 50(12B): 5486.
Kristova, V. et al. 1998. Early Postnatal Glutamate treatment
Results in Altered Vascular Responsiveness to Seratonin and Noradrenaline in Adult Rats.
Endocrine Regulations 32:133-139.
Kubo, T. et al. 1993. Neonatal Glutamate Can Destroy the
Hippocampal CA1 Structure and Impair Discrimination Learning in Rats. Brain
Research 616:311-314.
Kurozumi, K. et al. 1990. Generation of Inositol Phosphates, Cytosolic
Ca2+, and Secretion of Noradrenaline in PC12 Cells Treated with Glutamate. FEBS
Lett. 270 (1-2): 225-8.
Lipton, S. and Rosenberg, P. 1994. Excitatory Amino Acids as a Final Common
Pathway for Neurologic Disorders. New England Journal of Medicine. 330: 613-622.
Lipton, Stuart A. 1998. Excitotoxic Apoptosis and Necrosis in AIDS Dementia
and Stroke: Potential Treatment with NMDA Open-channel Blockers and Nitric Oxide Related
Species. Speaker, NIDA meeting, The Glutamate Cascade. Brigham and Women’s
Hospital and Harvard Medical School.
Liu, W. K. et al. 1989. Effects of Neonatal Monosodium-L-Glutamate
Treatment on Rat Alveolar Macrophages. Chemical Biological Interactions
69 (2-3): 193-201.
Liu, M. T. et al. 1999. Identification and characterization of
Glucoresponsive Neurons in the Enteric Nervous System. Journal of
Neuroscience 19:10305-10317.
Lovinger, David M. et al. 1990. Ethanol Inhibition of Neuronal Glutamate
Receptor Function. Ann. Med. 22 (4): 247-52.
Lundberg A/S, H. 2002. Data on Ebixa for Treatment of Alzheimer's
Disease. H.Lundberg A/S Press Release #73 Date 22-07-2002
Machado, U. F. et al. 1993. Decreaeed Glucose Transporter GLUT 4
Content in Insulin-Sensitive Tissues of Obese Aurothioglucose- and Monosodium
Glutamate-Treated Mice. Hormone and Metabolic Research 25(9):462-5.
Magalhaes, J. R. 1989. Ammonium Assimilation in Different Plant Species
as Affected by Nitrogen Form and pH Control in Solution Culture. Fertilizer
Research 21 (1): 1-6.
Margarinos, A. M. et al. 1988. Regulation of the Central Nervous
System-Pituitary-Adrenal Axis in Rats After Neonatal Treatment With Monosodium Glutamate.
Neuroendocrinology 48 (2): 105-111.
Marc, R. E. and Lam, D.M.K. 1981. Uptake of Aspartic and Glutamic Acid by
Photoreceptors in Goldrish Retina. Proc. Natl. Acad. Sci. 78: 7185-7189.
Marinez, F. et al. 1993. Neuroexcitatory Amino Acid Levels in Plasma and
Cerebrospinal Fluid During Migraine Attacks. Cephalagia 13(2):89-93.
Maulucci-Gedde, M and D. W. Choi. May 1987. Coritical Neurons Exposed to
Glutamate Rapidly Leak Preloaded Chromium. Experimental Neurology 2:
420-429.
Max, Mitchell B. 1998. Effect of Glutamate Blockers on Human Pain. Speaker,
NIDA meeting, The Glutamate Cascade. Institute of Dental Research, National Institutes
of Health.
McDonald, J. W. and M.V Johnston. 1993. Excitatory Amino Acid
Neurotoxicity in the Developing Brain. NIDA Research Monograph
133:185-205.
McMahon, Harvey T. et al. 1990. Alpha-Latrotoxin Releases Both Vesicular
and Cytoplasmic Glutamate From Isolated Nerve Terminals. Journal of
Neurochemistry 55 (6) 2039-47.
Miaskowiak, B. and M. Partyka. 1993. Effects of Neonatal Treatment with
MSG Monosodium Glutamate on Hypothalamo-Pituitary-Thyroid Axis in Adult Male Rats.
Histology and Histopathology 8(4):731-4.
Miaskowiak, B. and M. Partyka. 1993. Effect of Perinatal Administration
of Monosodium Glutamate MSG on the Reproductive System of the Male Rat. Endokrynologia
Polska 44 (4):497-505.
Michaels, R. L. and S. M. Rothman. 1990. Glutamate Neurotoxicity in
Vitro: Antagonist Pharmacology and Intracellular Calcium Concentrations. Journal
of Neuroscience 10 (1): 283-292.
Michaelis, E. K. 1990. Glutamate Receptor Changes in Brain Synaptic
Membranes From Human Alcoholics. Neurochem. Research 15 (11):
1055-63.
Milani, D. et al. 1991. Excitatory Amino-Acid Induced Alterations
of Cytoplasmic Free Calcium in Individual Cerebellar Granule Neurons: Role in
Neurotoxicity. J. Neurosci. Res. 28 (3): 434-41.
Miller, S. M. and B. Magasanik. 1990. Role of NAD-Linked Glutamate
Dehydrogenase in Nitrogen Metabolism in Saccharomyces Cerevisiae. Journal of
Bacteriology 172(9): 4927-35.
Miyamoto, M et al. 1989. Antioxidants Protect Against Glutamate-Induced
Cytotoxicity in a Neuronal Cell Line. Journal of Pharmacology and
Experimental Therapy 250 (3) 1132-1140.
Mohammed, A. K. et al. 1990. Behavioural Deficits and
Seratonin Depletion in Adult Rats After Transient Infant Nasal Viral Infection.
Neuroscience 35 (2): 355-63.
Morrison, John H. 1998. Glutamate Receptor Plasticity in the Hippocampus:
Implications for Aging. Speaker, NIDA meeting, The Glutamate Cascade Fishberg
Research Center for Neurobiology and Mount Sinai School of Medicine.
Mural, R. J. et al. 1990. Examination of the Intersubunit Interaction
Between Glutamate-48 and Lysine-168 of Ribulose-Bisphosphate Carboxylase/Oxygenase by
Site-Directed Mutagenisis. J. Biol. Chemistry 265(11): 6501-6505.
Murphy, T. H. et al. 1990. Immature Cortical Neurons are Uniquely
Sensitive To Glutamate Toxicity by Inhibition of Cystine Uptake. FASEB
Journal 4 (6): 1624-1633.
Murphy, T. H. et al. 1991. Enhanced NAD (P) H:Quinone Reductase Activity
Prevents Glutamate Toxicity Produced by Oxidative Stress. Journal of
Neurochemistry 56 (3): 990-995.
Murphy, T. H et al. 1989. Glutamate Toxicity in a Neuronal Cell Line
Involves Inhibition of Cystine Transport Leading to Oxidative Stress. Neuron
2 (6): 1547-58.
Murphy, T.H. and J. M. Baraban. 1990. Glutamate Toxicity In
Immature Cortical Neurons Precedes Development of Glutamate Receptor Currents. Dev.
Brain Research 57 (1): 146-150.
Mytilineou, C et al. 1997. L-(-)Desmethyiselegeline, a Metabolite of
Selegeline (L-(-)-deprenyl, Protects Mesencephalic Dopamine Neurons From Excitotoxicity in
Vitro. J Neurochem 68: 434-436.
Miyamoto, M. and Coyle J. 1990. Idebenone Attenuates Neuronal Degeneration
Induced by Intrastriatal Injection of Excitotoxins. Exp Neurol 108: 38-45.
Miyamoto, M. et al. 1989. Antioxidants Protect Against Glutamate-induced
Cytotoxicity in a Neuronal Cell Line. J Pharmacol Exp Ther 250: 1132-1140.
Murphy, Timothy H. 1989. Glutamate Toxicity in a Neuronal Cell Line Involves
Inhibition of Cystine Uptake Leading to Oxidative Stress. Ph.D. dissertation. The
Johns Hopkins University. Dissertation Abstracts Online. 50(07B): 2863.
Nakanishi, Koji, et al. 1990. Philanthotoxin-433 (PHTX-433), A
Non-competitive Glutamate Receptor Inhibitor. Pure Applied Chemistry 62
(7): 1223-30.
Nenoff, P. et al. 1993. In Vivo Assessment of Insulin Binding in
Different Organs of Growing and Adult Glutamate-Induced Obese Rats. Experimental
and Clinical Endocrinology 101(4):215-21.
Nishimura, Atsushi. 1990. Neonatal Glutamate-Induced Cerebral
Cortical Degeneration in Rats. Nichidai Igaku Zasshi 49 (12):
1131-9.
Nowak, L., Bregestovski, P. et al. 1984. Magnesium Gates Glutamate-activated
Channels in Mouse Central Neurones. Nature 307: 462-465.
O' Brien, J. et al. 1984. Toxicity of Maillard Reaction Products of
Monosodium Glutamate and Glucose in Rats. Irish Journal of Food Science and
Technology 8 (1): 77.
O' Brien, J. and R. Walker. 1988. Toxicological Effects of Dietary
Maillard Reaction Products in the Rat. Food and Chemical Toxicology 26
(9): 775-784.
O’Hearn, E. and Molliver, M.E. 1999. Neurotoxins and Neuronal Death: An
Animal Model of Excitotoxicity. In V.E. Koliatsos (ed): Cell Death and Diseases of the
Nervous System. Totowa, Humana Press. pp 221-245.
Olney, J. W. and M. T. Price. 1986. Cholinergic Neurotoxicity:
Mechanisms and Prevention. Washington University, St. Louis MO Dept of
Psychiatry Annual Report.
Olney, J. et al. 1998. Excitotoxic Neurodegeneration in Alzheimers Disease. Arch
Neurol 54: 1234-1240.
Olney, J.W., Wozniak, D.F., Farber, N.B. 1997. Excitotoxic Neurodegeneration
in Alzheimer Disease, New Hypothesis and New Therapeutic Strategies. Arch Neurol Oct:
54(10): 1234-1240.
Olney, J.W. et al. 1996. Increasing Brain Tumor Rates: Is there a
Link to Aspartame? Journal of Neuropathology and Experimental
Neurology 55:1115-23.
Olney, J. W.1994. Excitotoxins in Foods.
Neurotoxicology 15:535-44.
Olney, J. W. 1990. Excitotoxin Mediated Neuron Death in Youth and Old
Age. Progress in Brain Research 86:37-51.
Olney, J. W. 1990. Excitotoxin Amino Acids and Neuropsychiatric
Disorders. Annual Review of Pharmacology and Toxicology 30:47-71.
lney, J. 1989. Glutamate, a Neurotoxic Transmitter. J Child Neurol 4:
218-226.
Olney, J.W. and M.T. Price. 1980. Neuroendocrine Interactions of
Excitatory and Inhibitory Amino Acids. Brain Research Bulletin 5
(Suppl 2): 361-368.
Olney, J. W. et al. 1977. Neurotoxic Effects of Glutamate on Mouse Area
Postrema. Brain Research 120: 151-157.
Olney, J.W. 1974. Toxic Effects of Glutamate and Related Amino Acids on the
Developing Central Nervous System. Inherited Disorders of Amino Acid Metabolism, W.
N. Nylan, New York, Wiley.
Olney, J. W. et al. 1973. Brain-Damaging Potential of Protein
Hydrolysates. New England Journal of Medicine 289: 391-393.
Olney, J. W. et al. 1971. Cytotoxic Effects of Acidic and Sulphur
Containing Amino Acids on the Infant Mouse Central Nervous System. Experimental
Brain Research 14:61-76.
Olney, J.W. and O.L. Ho. 1970. Brain Damage in Infant Mice Following Oral
Intake of Glutamate, Aspartate or Cysteine. Nature 227:609-610.
Olney, J.W. 1969. Glutamate-induced retinal degeneration in neonatal
mice. Journal of Neuropathology and Experimental Neurology
28:455-474.
Olney, J.W. 1969. Brain Lesions, Obesity, and Other Disturbances in Mice
Treated with Monosodium Glutamate. Science 164:719-721.
Olney, J. W. and L.G. Sharpe. 1969. Brain Lesions in an Infant
Rhesus Monkey Treated With Monosodium Glutamate. Science
166:386-388.
Orpana, Arto K. 1990. Ethanol-Induced Inhibition of Testosterone
Biosynthesis in Rat Leydig Cells: Role of L-Glutamate and Pyruvate. Journal
of Steroid Biochem. 36 (5): 473-8.
Pike, R.N., D. Bagarozzi Jr and J. Travis. 1997. Immunological
cross-reactivity of the Major Allergen from Perennial Ryegrass (Lolium Perenne), L01 pI,
and the Cysteine Proteinase, Bromelain. Int. Arch. Allergy Immunol. 1123:
412-414.
Pol, A. et al (1990). Glutamate, the Dominant Excitatory Transmitter in
Neuroendocrine Regulation. Sci 250: 1276-1278
Portais, J. C. et al. 1991. Magnetic Resonance Spectroscopy and
Metabolism. Applications of Proton and 13C NMR to the Study of Glutamate Metabolism
in Cultured Glial Cells and Human Brain In Vivo. Biochimie 73
(1): 93-7.
Privat, Alain et al. 1990. Neuronal Protection by Phenycyclidines: In
Vitro Studies. Actual. Chim. Ther. 17: 187-200.
Pulvirenti, Luigi. 1998. Glutamate During the Natural History of
Psychostimulant Dependence: Synaptic Plasticity and Medications Development. Speaker,
NIDA meeting, The Glutamate Cascade. University of Rome – Tor Vergata, Italy.
Rao, G. S. and K. P. Pandya. 1989. Release of 2-Thiobarbituric Acid
Reactive Products From Glutamate or Deoxyribonucleic Acid by 1, 2, 4-Benzenetriol or
Hrdroquinone in the Presence of Copper Ions. Toxicology 59 (1): 59-65.
Rawls, S.M., McGinty, J.F., 1998. Presynaptic Kappa Opioid and Muscarinic
Receptors Inhibit the Calcium-dependent Component of Evoked Glutamate Release from
Striatal Synaptosomes. J Neurochem. 73: 1058-1065.
Rawls, S.M., McGinty, J.F. 1998. Kappa Receptor Activation Attenuates
L-trans-PDC-evoked Glutamate Levels in the Striatum. J Neurochem 70: 626-634.
Rigdon, G. C. et al. 1989. Effect of Perinatal Monosodium Glutamate
Administration on Visual Evoked Potentials of Juvenile and Adult Rats. Neuro-Toxicology
and Teratology 11 (2): 121-128.
Roberts, H.J. 1988. Reactions Attributed to Aspartame-containing Products:
551 Cases. J App Nutr 40: 85-94.
Roberts, H.J. 1995. Aspartame and Headache. Neurology 45:
1631-1633.
Roberts, H.J. 1988. Aspartame (NutraSweet®)-associated Epilepsy. Clin
Res 36: 349A.
Roberts, H.J. 1988 Complications Associated with Aspartame (NutraSweet®) in
Diabetes. Clin Res 3: 489A.
Roberts, H.J. 1991. Joint Pain Associated with Aspartame Use. Townsend
letter for Doctors. May: 375-376.
Roberts, H.J., 1993 Aspartame-associated Dry Mouth (Xerostomia). Townsend
letter for Doctors. February: 201-202.
Rochelle, Lori G. et al. 1990. Chlordecone Impairs Sodium-Stimulated
l-(3h) Glutamate Transport and Mobility of 16-Doxyl Stearate in Rat Liver Plasma Vesicles.
Toxicol. Appl. Pharacol. 105 (2): 234-42.
Rogawski, Michael E. 1998. Glutamate Neurotransmission in Epilepsy: New
Treatment Strategies. Speaker, NIDA meeting, The Glutamate Cascade. National
Institute of Neurological Disorders and stroke, National Institutes of Health.
Rosenberg, P.A., and E. Aizenman. 1989. Hundred-fold Increase in
Neuronal Vulnerability to Glutamate Toxicity in Astrocyte-Poor Cultures of Rat Cerebral
Cortex. Neuroscience Letters 103 (2): 162-168. 116 (3) 399.
Rothstein, J.D. et al. 1992. Decreased Glutamate Transport by the Brain
and Spinal Cord in Amyotropic Lateral Sclerosis. New England Journal of
Medicine 326:1464-1468.
Ruijter, J. M. and R. E. Baker. 1990. The Effects of Potassium-Induced
Depolarization, Glutamate Receptor Antagonists and N-Methyl-D-Aspartate on Neuronal
Survival in Cultured Neocortex Explants. Int. J. Dev. Neurosci. 8 (4):
361-70.
Sanico, Alvin, et al. 2000. Researchers Present New Theory for Allergic
Diseases. American Journal of Respiratory and Critical Care Medicine.
Schweitzer, L. et al. 1991. Glutamate Neurotoxicity in Rat
Auditory System Cochlear Nuclear Complex. Neurotoxicology Teratol
13 (2): 189-194.
Shapiro, B. H. et al. 1993. Irreversible Suppression of Growth
Hormone-Dependent Cytochrome P450 2C11 in Adult Rats Neonatally Treated with Monosodium
Glutamate. Journal of Pharmacology and Experimental Therapeutics
265(2):979-84.
Shinora, S. et al. 1991. Inhibitory Effect of
CCK-8 and Ceruletide on Neuronal Cell Death Induced by Glutamate and its Possible
Mechanism. 64th Annual Meeting of the Japanese Pharmacological Society
55 (Suppl. 1): 303.
Siegal, T. et al. 1990. Experimental Neoplastic Spinal Cord Compression:
Effect of Anti-Inflammatory Agents and Glutamate Receptor Antagonists on Vascular
Permeability. Neurosurgery 26 (6): 967-70.
Simantov, R. 1989. Glutamate Neurotoxicity in Culture Depends on the
Presence of Glutamine: Implications for the Role of Glial Cells in Normal and Pathological
Brain Development. Journal of Neurochemistry 52 (6): 1694-9.
Singh, J. et al. 1990. Effect of Aspartate and Glutamate on Carbon
Tetrachloride Induced Liver Damage in Rats. Indian Journal of
Experimental Biology 28 (12): 1180-3.
Smith, J.D. et al. 2001. Relief of Fibromyalgia Symptoms Following
Discontinuation of Dietary Excitotoxins. Annals of Pharmacotherapy
35(6):702-6.
Solimena, M et al. 1990. Auto-antibodies to GABA-ergic Neurons and
Pancreatic Cells in Stiff-man Syndrome. New England Journal of Medicine
322:1555-1560.
Sorg, O. et al. 1997. Inhibition of Astrocyte Glutamate Uptake by Reactive
Oxygen Species: Role of Antioxidant Enzymes. Mol. Med 7: 431-440.
Sucher, N.J. et al. 1991. Calcium Channel Antagonists Attenuate NMDA
Receptor-Mediated Neurotoxicity of Retinal Ganglion Cells in Culture. Brain
Research 551 (1-2): 297-302.
Summers, M.J. 1995. Administration of Glutamate Following a
Reminder Induces Transient Memory Loss in Day-old Chicks. Brain Research
3(1):1-8.
Tamura, Y. et al. 1991. Ifenprodil-Induced Protection Against Glutamate
Cytotoxicity in Primary Culture of Cortical Neurons. 64th Annual Meeting of
the Japanese Pharmacological Society 55 (Suppl. 1): 297.
Tang-Christensen, M. et al. 1998. Glucagon-like Peptide 1 7-36 amide's
Central Inhibition of Feeding and Peripheral Inhibition of Drinking Are Abolished by
Neonatal Monosodium Glutamate Treatment. Diabetes 47(4):530-7
Tarkowski, S. 1974. Activity of Glutamate Decarboxylase in the Brain of
Rats Exposed to Carbon Disulfide. International Archiv Fuer Arbeitsmedizin
33 (1) 79-82.
Teal, G.E. et al. 1998. Increased Glutamatergic Neurotransmission and
Oxidative Stress After Alcohol Withdrawal. Am J Psychiat 155: 726-732.
Terrian, David, M. et al. 1991. Domoic Acid Enhances the
Potassium-Evoked Release of Endogenous Glutamate From Guinea Pig Hippocampal Mossy Fiber
Synaptosomes. Brain Research 551 (1-2): 303-7.
Tomita, M et al. 1990. Ionic Concentration of Shifting Fluid During
Glutamate-Induced Swelling of Cultured Glioma Cells Estimated by the Cytocrit Technique.
Adv. Neurology 52: 558.
Tzimagiorgis, G. et al. 1991. Chromosomal Mapping of Glutamate
Dehydrogenase Gene Sequences to Mouse Chromosomes 7 and 14. Genomics
10 (1) 83-8.
Villalobos, Carlos et al. 1996. Functional Glutamate Receptors in a
Subpopulation of Anterior Pituitary Cells. FASEB J. 10: 654-660.
Vornov, J. J. and J. T. Coyle. 1991. Glutamate Neurotoxicity and the
Inhibition of Protein Synthesis in the Hippocampal Slice. Journal of
Neurochemistry 56 (3): 996-1006.
Walling, Anne D. Predicting Which Strokes Will Progress: Glutamate Levels.
1997. American Family Physician: 55(7): 2532(1).
Wang, J.Q., McGinty, J.F. 1999. Glutamate-dopamine Interactions Mediate the
Effects of Psychostimulant Drugs. Addiction Biology. 4: 143-152.
Weeing-Verhoeff, E. J. D. et al. 1990. Involvement of
Aspartic and Glutamic Residues in Kringle-2 of Tissue-Type Plasminogen activator in Lysine
Binding, Fibrin Binding and Stimulation of Activity as Revealed by Chemical Modification
and Oligonucleotide-Directed Mutagenesis. Protein Engineering 4
(2) 191-8.
Whetsell, W. and Shapira, N. 1993. Biology of Disease. Neuroexcitation,
Excitotoxicity and Human Neurological Disease. Lab Invest 68: 372-387.
Wolf, Marina E. 1998. Glutamate-Mediated Neuroplasticity: Role in Amphetamine
Addiction. Speaker, NIDA meeting, The Glutamate Cascade. The Chicago
Medical School.
Wong, C. C. et al. 1988. Effect of Neonatal Monosodium-L-Glutamate
Treatment on the Response of Isolated Uterine Preparation To Various Uterine Contraction
Stimulators. Gen. Pharmacol. 19 (5): 673-677.
Wong, P.T. et al. 1997. Deficits in Water Escape Performance and
Alterations in Hippocampal Cholinergic Mechanisms Associated with Neonatal Monosodium
Glutamate Treatment in Mice. Pharmacology, Biochemistry and Behaviour
57(1-2):383-8.
Xu, C. J. et al. 1997. Effect of Phosphomonoesters, Phosphodiesters, and
PhosphoCreatine on Glutamate Uptake by Synaptic Vesicles. Molecular and
Chemical Neuropathology 32(1-3):89-99.
Yamamoto, T, et al. 1993. Plasma Levels of Insulin-like Growth Factor-I
are Reduced at one Week of Age in Monosodium L-Glutamate-Treated Mice. Endocrine
Journal 40(4):461-5.
Yanai, A. et al. 1991. 4-0 Methylpyridoxine-Induced Convulsion
Accompanied by a Decreased Cerebral GABA Level in Guinea Pigs. 64th Annual
Meeting of the Japanese Pharmacological Society 55 (Suppl. 1): 303.
Yokota, I. et al. 1990. Molecular Basis of Medium Chain Acyl-Coenzyme A
Dehydrogenase Deficiency. An A to G Transition at Position 985 That Causes a
Lysine-304 to Glutamate Substitution in the Mature Protein is the Single Prevalent
Mutation. J. Clinical Invest. 86 (3): 1000-1003.
Yu, T. et al. 1997. Effects of Maternal Oral Administration of
Monosodium Glutamate at a Late Stage of Pregnancy on Developing Mouse Fetal Brain.
Brain Research 747(2):195-206.
Zeevalk, G. D. and W. J. Nicklas. 1990. Chemically Induced Hypoglycemia
and Anoxia: Relationship To Glutamate Receptor-Mediated Toxicity in Retina. J.
Pharmacology and Experimental Therapy 253 (3): 1285-1292.
Zharikov, S. I. et al. 1990. Effect of Alpha-Latrotoxin on the Processes
of Glutamate Uptake and Release in Rat Brain Synaptosomes. Biol.
Membr. 7(10): 101321
Zhao, X. N. et al. 1990. Morphine Enhancement of Glutamate and Kainic
Acid Neurotoxicity. Met. Ions Biol. Med. Proc. Int. Symp. pp 156-8.
Zieglgansberger, Walter and Planck, M. 1998. Acamprosate, a Novel
Anti-craving Compound Acts Via Glutamatergic Pathways. Speaker, NIDA meeting, The
Glutamate Cascade. Institute of Psychiatry, Munich, Germany.
Zukin, Stephen R. 1998. Schizophrenia: A Glutamatergic Perspective. Speaker,
NIDA meeting, The Glutamate Cascade. National Institute on Drug Abuse, National
Institutes of Health.